Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
Checkmate 017: A Phase 3 Study of Nivolumab vs Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
— May 28, 2015
Read Article
Final Overall Survival Results of the Phase 3 PROCLAIM Trial
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
— May 28, 2015
Read Article
Necitumumab in Metastatic Squamous NSCLC: Establishing a Value-Based Cost
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
— May 28, 2015
Read Article
Phase 1-1B Trial of Tivantinib in Combination with Carboplatin and Pemetrexed as First-Line Treatment in Patients with Advanced Nonsquamous NSCLC or Malignant Pleural Mesothelioma
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
— May 28, 2015
Read Article
A Phase 3B/4 Safety Trial of Nivolumab (NIVO) in Patients with Advanced or Metastatic NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
— May 28, 2015
Read Article
Phase 3 Trial (Checkmate 057) of Nivolumab (NIVO) Versus Docetaxel (DOC) In Advanced Non Squamous Cell (Non-SQ) NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
— May 28, 2015
Read Article
Safety Overview of the CLLM1 Trial: Lenalidomide Maintenance Therapy After Frontline Chemoimmunotherapy in High-Risk CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
— January 13, 2015
Read Article
Functional Evidence that Ibrutinib Blocks Leukemia Cell Proliferation and Trafficking and Promotes Leukemia Cell Death
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
— January 13, 2015
Read Article
The Combination of Alemtuzumab and Ofatumumab in Previously Untreated CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
— January 13, 2015
Read Article
Ublituximab plus TGR-1202 in Heavily Pretreated and High-Risk CLL
ASH 2014 - CLL
,
ASH Highlights
Conference Correspondent
— January 13, 2015
Read Article
Page 31 of 44
28
29
30
31
32
33
34
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma